Co-founder of Avisi Technologies named one of the Greater Philadelphia’s Inno Under 25
Along with co-founder Brandon Kao, Rui Jing Jiang started Avisi Technologies in 2017, developing VisiPlate, a nanotechnology-enabled ocular implant to treat glaucoma. Read More →
Avisi closed an oversubscribed Seed round
These funds will be instrumental in advancing #VisiPlate to clinical trials, growing our team, and taking us one step closer to helping tens of millions of patients preserve their vision. Read More →
Avisi Technologies: $1M NSF Grant
The funding will help prepare the team for clinical trials, which they plan to begin in 2021. Read More →
Avisi Technologies Eyes Goal of Human Trials With $1M National Science Foundation Grant
The Pennovation-based startup that makes an ocular implant to treat glaucoma also raised half a million in seed funding. Read More →